The Association of Statin Use and Statin Type and Cognitive Performance: Analysis of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Statin use and type have been variably associated with impaired or improved cognitive performance.

[1]  C. Carpenter,et al.  The Six-Item Screener to detect cognitive impairment in older emergency department patients. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[2]  V. Wadley,et al.  Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. , 2008, Journal of cardiac failure.

[3]  Yaakov Stern,et al.  Frequency and course of mild cognitive impairment in a multiethnic community , 2008, Annals of neurology.

[4]  Candice L. Garwood,et al.  Behavioral changes with paranoia in an elderly woman taking atorvastatin. , 2008, The American journal of geriatric pharmacotherapy.

[5]  K. Hall,et al.  Association of statin use with cognitive decline in elderly African Americans , 2007, Neurology.

[6]  C. Moy,et al.  The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design , 2005, Neuroepidemiology.

[7]  R. Doody,et al.  Cardiovascular Risk Factors and Cognitive Function in Adults 30–59 Years of Age (NHANES III) , 2004, Neuroepidemiology.

[8]  J. Caballero,et al.  Do statins slow down Alzheimer's disease? A review , 2004, Journal of clinical pharmacy and therapeutics.

[9]  Sudha Seshadri,et al.  Framingham Stroke Risk Profile and Lowered Cognitive Performance , 2004, Stroke.

[10]  Daniel W. Jones,et al.  Cognitive Impairment Associated with Atorvastatin and Simvastatin , 2003, Pharmacotherapy.

[11]  I. McKeith,et al.  Effects of hypertension on attention, memory, and executive function in older adults. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[12]  F. Pezzella,et al.  Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population , 2003, Journal of Neurology.

[13]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[14]  Christopher M Callahan,et al.  Six-Item Screener to Identify Cognitive Impairment Among Potential Subjects for Clinical Research , 2002, Medical care.

[15]  B. Golomb,et al.  Statins and dementia. , 2001, Archives of neurology.

[16]  A. Orsi,et al.  Simvastatin‐Associated Memory Loss , 2001, Pharmacotherapy.

[17]  O. Gureje,et al.  Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. , 2001, JAMA.

[18]  F. Gengo,et al.  Effects of treatment with lovastatin and pravastatin on daytime cognitive performance , 1995, Clinical cardiology.

[19]  C. Ashton,et al.  Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. , 1994, British journal of clinical pharmacology.

[20]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[21]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[22]  K. Yaffe,et al.  Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2009 .

[23]  Sterling C. Johnson,et al.  Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[24]  P. Hartge,et al.  Reporting participation in epidemiologic studies: a survey of practice. , 2006, American journal of epidemiology.